Geoff Nichol

3.3k total citations · 2 hit papers
9 papers, 2.5k citations indexed

About

Geoff Nichol is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Geoff Nichol has authored 9 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Geoff Nichol's work include vaccines and immunoinformatics approaches (3 papers), Immunotherapy and Immune Responses (3 papers) and Virus-based gene therapy research (2 papers). Geoff Nichol is often cited by papers focused on vaccines and immunoinformatics approaches (3 papers), Immunotherapy and Immune Responses (3 papers) and Virus-based gene therapy research (2 papers). Geoff Nichol collaborates with scholars based in United States, Romania and United Kingdom. Geoff Nichol's co-authors include Michael Yellin, Jeffrey S. Weber, Gwendolyn Binder-Scholl, Gary Lee, Bruce L. Levine, Pablo Tebas, Ian Frank, Michael C. Holmes, Ronald G. Collman and Michael Kalos and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Geoff Nichol

9 papers receiving 2.5k citations

Hit Papers

Gene Editing of CCR5 in Autologous CD4 T Cells of... 2005 2026 2012 2019 2014 2005 250 500 750

Peers

Geoff Nichol
Jonathan H. Esensten United States
Daniel J. Dairaghi United States
Ge Ma China
Sasikanth Manne United States
Stuart Naylor United Kingdom
Qingsheng Li United States
Geoff Nichol
Citations per year, relative to Geoff Nichol Geoff Nichol (= 1×) peers Christopher W. Peterson

Countries citing papers authored by Geoff Nichol

Since Specialization
Citations

This map shows the geographic impact of Geoff Nichol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoff Nichol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoff Nichol more than expected).

Fields of papers citing papers by Geoff Nichol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoff Nichol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoff Nichol. The network helps show where Geoff Nichol may publish in the future.

Co-authorship network of co-authors of Geoff Nichol

This figure shows the co-authorship network connecting the top 25 collaborators of Geoff Nichol. A scholar is included among the top collaborators of Geoff Nichol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoff Nichol. Geoff Nichol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Riley, Brigit E., Dominique Cartier, Kate Nesbitt, et al.. (2016). Development of an Optimized rAAV2/6 Human Factor 8 cDNA Vector Cassette for Hemophilia a Gene Therapy. Blood. 128(22). 1173–1173. 1 indexed citations
2.
Wechsler, Thomas, Kathleen Meyer, S. Kaye Spratt, et al.. (2015). ZFN-Mediated Gene Targeting at the Albumin Locus in Liver Results in Therapeutic Levels of Human FIX in Mice and Non-Human Primates. Blood. 126(23). 200–200. 3 indexed citations
3.
Tebas, Pablo, David Stein, Winson W. Tang, et al.. (2014). Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV. New England Journal of Medicine. 370(10). 901–910. 973 indexed citations breakdown →
5.
Sarnaik, Amod A., Bin Yu, Daohai Yu, et al.. (2010). Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma. Clinical Cancer Research. 17(4). 896–906. 157 indexed citations
6.
Weber, Jeffrey S., Steven O’Day, Walter J. Urba, et al.. (2008). Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma. Journal of Clinical Oncology. 26(36). 5950–5956. 369 indexed citations
7.
Attia, Peter, Giao Q. Phan, Ajay V. Maker, et al.. (2005). Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4. Journal of Clinical Oncology. 23(25). 6043–6053. 771 indexed citations breakdown →
8.
Nichol, Geoff, et al.. (1990). Inhaled Furosemide Inhibits Cough Induced by Low Chloride Content Solutions but Not by Capsaicin. American Review of Respiratory Disease. 142(1). 143–146. 98 indexed citations
9.
Lammers, Jan-Willem J., Ioannis Kioumis, Monica McCusker, et al.. (1990). Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man. Journal of Allergy and Clinical Immunology. 85(4). 763–769. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026